Ada Website Helper

    Subscribe to Updates

    Get the latest creative news from FooBar about art, design and business.

    What's Hot

    Pioneer Theater Company Announces Timely World Premiere of ‘A Distinct Society’ – @theU

    January 27, 2023

    How do we feel about disability and what are we going to say about it?

    January 27, 2023

    EEOC Releases Updated Guidance on ADA Requirements for Hearing-Impaired Individuals in the Workplace

    January 27, 2023
    Facebook Twitter Instagram
    Ada Website Helper
    • Home
    • Autism

      Jason Kelce and his wife, Kylie, are the driving force behind the Eagles Autism Foundation

      January 27, 2023

      Steinhardt introduces bill to make traffic stops safer for autistic drivers

      January 27, 2023

      “My twin has autism and my son said he didn’t see me as a human being.”

      January 27, 2023

      NIH Program Study Links Prenatal Perfluorononanoic Acid Exposure to Pediatric Autism-Related Features

      January 27, 2023

      NIH Program Study Links Prenatal Perfluorononanoic Acid Exposure to Pediatric Autism-Related Features

      January 27, 2023
    • Disabilities

      EEOC Releases Updated Guidance on ADA Requirements for Hearing-Impaired Individuals in the Workplace

      January 27, 2023

      Brandt introduces bill to ban organ donation discrimination based on disability

      January 27, 2023

      Learning disabilities – The Economic Times

      January 27, 2023

      Disabled couple happy with accessible OKC Habitat Home

      January 27, 2023

      Caregiver crisis hits LGBTQ older and disabled hardest

      January 27, 2023
    • Disability

      How do we feel about disability and what are we going to say about it?

      January 27, 2023

      Retirement and Disability Research Consortium Cooperation Agreement – ​​InsuranceNewsNet

      January 27, 2023

      How executives overcame obstacles and developed a sense of belonging

      January 27, 2023

      Here are the number of people living with a disability in Oxford

      January 27, 2023

      NIH is being asked to change its ‘Competent’ mission statement

      January 27, 2023
    • Literature

      Fusion of art, culture and literature

      January 27, 2023

      Exhibition: A major attraction for art and literary works at the Patiala Heritage Festival

      January 27, 2023

      TETE ATETE Latest Education News with Renowned Translators of Hindi and Urdu Literature | Global Education News

      January 27, 2023

      Didion Dunn archives acquired by the New York Public Library

      January 27, 2023

      Tete Atete with renowned translators of Hindi and Urdu literature – The Times of Bengal

      January 27, 2023
    • Living

      CT BBB Alert on Cost of Living Fraud

      January 27, 2023

      News and analysis for those planning or nearing retirement

      January 27, 2023

      Living with the Good and Evil of Jordan Poole

      January 27, 2023

      All Saints Abbey of Etna transformed into apartment life

      January 27, 2023

      Half Moon Bay shooting: Supervisor tours ‘dire’ living conditions at mushroom farm where farm worker was killed

      January 27, 2023
    • Society

      Pioneer Theater Company Announces Timely World Premiere of ‘A Distinct Society’ – @theU

      January 27, 2023

      Philly Mayor Richardson Dilworth Redevelopment Begins

      January 27, 2023

      Las Vegas Ace Star Chelsea Gray Joins Gaming Society Board of Directors

      January 27, 2023

      Purdue Northwest’s Leadership Institute and Society of Innovators Release 2023 Women on the Rise List and Reception – NWILife

      January 27, 2023

      Baird Named President and CEO of NC Aquarium Association

      January 27, 2023
    Facebook Twitter Instagram
    Ada Website Helper
    Home»Autism»SciSparc Signs Agreement with Soroka Medical Center to Conduct Clinical Trial in Autism Spectrum Disorder
    Autism

    SciSparc Signs Agreement with Soroka Medical Center to Conduct Clinical Trial in Autism Spectrum Disorder

    adawebsitehelper_ts8fwmBy adawebsitehelper_ts8fwmJanuary 9, 20234 Mins Read
    Facebook Twitter Pinterest LinkedIn WhatsApp Reddit Tumblr Email
    Share
    Facebook Twitter LinkedIn Pinterest Email


    Sai Park Co., Ltd.

    Sai Park Co., Ltd.

    ethics committee and the Israelites Ministry of Public Health approvalalready received for of Company’s study with its ownership SCI-210 treatment

    TEL AVIV, Israel, Jan. 9, 2023 (GLOBE NEWSWIRE) — SciSparc Ltd. (Nasdaq: SPRC) (the “Company” or “SciSparc”) is focused on developing therapeutics to treat disorders. is a professional clinical-stage pharmaceutical company. today announced that it has entered into an agreement with Soroka University Medical Center in Beersheva, Israel (“Soroka Medical Center”) to conduct our clinical study on SCI-210 in patients with autism. . Spectrum Disorder (“ASD”).

    In 2022, we received approval from the Israeli Ministry of Health and the Ethics Committee of Soroka University Medical Center, Beersheva, Israel, to conduct our clinical trial.

    Oz Adler, CEO of SciSparc, said: “The study in ASD strengthens our advanced clinical program, along with the Phase IIb clinical trial of SCI-110 in patients with Tourette syndrome and the Phase IIa clinical trial of SCI-110 in patients with Alzheimer’s disease and agitation. Soroka Medical Center is Israel’s leading medical center and co-founder and partner of the Israel National Center for Autism and Neurodevelopmental Research, which is dedicated to ASD A leading international center for innovation in translational research, diagnostics and interventions for and other neurodevelopmental conditions, Soroka Medical Center is another in an ongoing effort to collaborate with the world’s leading medical institutions. An example.”

    This trial will investigate the efficacy and safety of SciSparc’s drug candidate SCI-210, a proprietary combination of cannabidiol (“CBD”) and CannAmide™, compared to CBD monotherapy in the treatment of ASD.

    The aim of this study was to evaluate the safety, tolerability, and efficacy of SCI-210 in children with ASD in a randomized, double-blind, placebo-controlled crossover study. The study design included a 20-week, randomized, double-blind, placebo-controlled, crossover clinical trial in 60 children. The trial has three primary efficacy endpoints. Clinician-implemented clinical global impression improvement (CGI-I). and an effective therapeutic dose.

    ASD is a developmental brain condition that affects how a person perceives and interacts with others, causing problems with social interaction and communication. The term “spectrum” in autism spectrum disorders refers to a wide range of symptoms and severity.

    almost rhinoceros park Co., Ltd. (Nasdaq: SPRC):

    SciSparc Ltd. is a specialist clinical-stage pharmaceutical company led by an experienced team of senior management and scientists. SciSparc’s focus is to create and enhance a portfolio of cannabinoid pharmaceutical-based technologies and assets. With this focus, we are currently engaged in the following drug development programs based on THC and/or non-psychoactive CBD. SCI-160 for the treatment of pain; SCI-210 for the treatment of ASD and status epilepticus.

    Forward-Looking Statements:

    This press release contains forward-looking statements within the meaning of the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995 and other federal securities laws. For example, SciSparc has developed a plan to evaluate the potential benefits of SCI-210 treatment and the safety, tolerability and efficacy of SCI-210 in children with ASD in a randomized, double-blind, placebo-controlled study. Forward-looking statements are used in discussions. crossover research. Past results of scientific studies and clinical and preclinical trials are no guarantee that the conclusions of future studies or trials will suggest the same or similar conclusions. Such statements deal with future events and are based on SciSparc’s current expectations and are subject to various risks and uncertainties, and SciSparc’s actual results, performance or achievements may not be accurate in this press release. It may differ materially from what is stated or implied in the description. The forward-looking statements contained in or implied in this press release are made in SciSparc’s Annual Report on Form 20-F filed with the SEC on April 28, 2022 under the heading “Risk Factors.” are subject to other risks and uncertainties, including those discussed in It was later filed with the U.S. Securities and Exchange Commission. Except as otherwise required by law, SciSparc makes forward-looking statements only as of the date they are made, whether as a result of new information, future events, circumstances or otherwise. disclaims any intention or obligation to update or revise any statements relating to

    Investor Contact:
    IR@scisparc.com
    Phone: +972-3-6167055



    Source link

    Share. Facebook Twitter Pinterest LinkedIn WhatsApp Reddit Tumblr Email
    adawebsitehelper_ts8fwm
    • Website

    Related Posts

    Autism January 27, 2023

    Jason Kelce and his wife, Kylie, are the driving force behind the Eagles Autism Foundation

    Autism January 27, 2023

    Steinhardt introduces bill to make traffic stops safer for autistic drivers

    Autism January 27, 2023

    “My twin has autism and my son said he didn’t see me as a human being.”

    Autism January 27, 2023

    NIH Program Study Links Prenatal Perfluorononanoic Acid Exposure to Pediatric Autism-Related Features

    Autism January 27, 2023

    NIH Program Study Links Prenatal Perfluorononanoic Acid Exposure to Pediatric Autism-Related Features

    Autism January 27, 2023

    ADHD strongly linked to anxiety, depression and autism: study

    Leave A Reply Cancel Reply

    Don't Miss
    Society January 27, 2023

    Pioneer Theater Company Announces Timely World Premiere of ‘A Distinct Society’ – @theU

    Since 1962, the Pioneer Theater Company (located here on campus) has brought the arts to…

    How do we feel about disability and what are we going to say about it?

    January 27, 2023

    EEOC Releases Updated Guidance on ADA Requirements for Hearing-Impaired Individuals in the Workplace

    January 27, 2023

    CT BBB Alert on Cost of Living Fraud

    January 27, 2023
    Stay In Touch
    • Facebook
    • Twitter
    • Pinterest
    • Instagram
    About Us

    This website provides information about disability and other things. Keep Supporting Us With the Latest News and we Will Provide the Best Of Our To Makes You Updated All Around The World News. Keep Sporting US.

    Our Picks

    Pioneer Theater Company Announces Timely World Premiere of ‘A Distinct Society’ – @theU

    January 27, 2023

    How do we feel about disability and what are we going to say about it?

    January 27, 2023

    EEOC Releases Updated Guidance on ADA Requirements for Hearing-Impaired Individuals in the Workplace

    January 27, 2023

    Subscribe to Updates

    Get the latest creative news from SmartMag about art & design.

    Facebook Twitter Instagram Pinterest
    • Home
    • Contact us
    • DMCA
    • Privacy Policy
    © 2023 adawebsitehelper. Designed b yadawebsitehelper.

    Type above and press Enter to search. Press Esc to cancel.